Achieve Life Sciences (ACHV)
NASDAQ:ACHV
Want to see ACHV full AI Analyst Report?
Total Valuation
Achieve Life Sciences has a market cap or net worth of $489.68M. The enterprise value is $230.96M.
Market Cap$489.68M
Enterprise Value$230.96M
Share Statistics
Achieve Life Sciences has 102,659,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding102,659,060
Owned by Insiders0.87%
Owned by Institutions7.02%
Financial Efficiency
Achieve Life Sciences’s return on equity (ROE) is -2.54 and return on invested capital (ROIC) is -150.47%.
Return on Equity (ROE)-2.54
Return on Assets (ROA)-1.31
Return on Invested Capital (ROIC)-150.47%
Return on Capital Employed (ROCE)-1.68
Revenue Per Employee0.00
Profits Per Employee-2.19M
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Achieve Life Sciences is ―. Achieve Life Sciences’s PEG ratio is -4.92.
PE Ratio―
PS Ratio0.00
PB Ratio10.07
Price to Fair Value10.07
Price to FCF-4.38
Price to Operating Cash Flow-5.38
PEG Ratio-4.92
Income Statement
In the last 12 months, Achieve Life Sciences had revenue of 0.00 and earned -54.65M in profits. Earnings per share was -1.25.
Revenue0.00
Gross Profit-228.00K
Operating Income-54.88M
Pretax Income-54.65M
Net Income-54.65M
EBITDA-54.65M
Earnings Per Share (EPS)-1.25
Cash Flow
In the last 12 months, operating cash flow was -45.31M and capital expenditures -3.00K, giving a free cash flow of -45.31M billion.
Operating Cash Flow-45.31M
Free Cash Flow-45.31M
Free Cash Flow per Share-0.44
Dividends & Yields
Achieve Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.70
52-Week Price Change41.72%
50-Day Moving Average4.11
200-Day Moving Average4.07
Relative Strength Index (RSI)46.39
Average Volume (3m)1.63M
Important Dates
Achieve Life Sciences upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Achieve Life Sciences as a current ratio of 4.39, with Debt / Equity ratio of 140.03%
Current Ratio4.39
Quick Ratio4.39
Debt to Market Cap0.07
Net Debt to EBITDA0.11
Interest Coverage Ratio-67.01
Taxes
In the past 12 months, Achieve Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Achieve Life Sciences EV to EBITDA ratio is -3.86, with an EV/FCF ratio of -4.26.
EV to Sales0.00
EV to EBITDA-3.86
EV to Free Cash Flow-4.26
EV to Operating Cash Flow-4.26
Balance Sheet
Achieve Life Sciences has $29.27M in cash and marketable securities with $14.95M in debt, giving a net cash position of $14.32M billion.
Cash & Marketable Securities$29.27M
Total Debt$14.95M
Net Cash$14.32M
Net Cash Per Share$0.14
Tangible Book Value Per Share$0.45
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Achieve Life Sciences is $13.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$13.20
Price Target Upside158.82% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast16.68%